期刊文献+

放疗配合化疗治疗恶性胶质瘤术后患者的临床疗效分析 被引量:1

Analysis of clinical efficacy of radiotherapy combined with chemotherapy on treatment of patients after malignantglioma
下载PDF
导出
摘要 目的探索放疗配合化疗在恶性胶质瘤术后治疗中的临床应用价值。方法选择2006年1月~2011年1月我科就诊的65例恶性胶质瘤术后患者,机械抽样随机将其中的42例分为观察组,采用放疗+化疗,余23例为对照组,采用放疗。结果观察组缓解率为88.1%,3年生存率为47.6%,均高于对照组(P<0.05);胃肠道反应、脑水肿加重及骨髓抑制发生率两组差异无统计学意义(P>0.05)。结论放疗配合化疗不但可显著改善近期疗效,也可显著提高远期疗效,且较为安全。 Objective To explorer the clinical application value of radiotherapy combined with chemotherapy on treatment of patients after malignant glioma.Methods 65 cases of patients with malignant glioma that were treated in our department between January 2006 and January 2008.42 cases of patients were mechanical sampling randomly divided into observation group,and the remainder into control group.Observation group were treated by radiotherapy combined with chemotherapy,and control group by radiotherapy.Results The remission rate of observation group was 88.1% and 3-year survival rate was 47.6%,significantly higher than control group(P0.05).The difference of incidence of gastrointestinal tract,brain edema and bone marrow suppression wasn't significant(P0.05).Conclusion Radiotherapy combined with chemotherapy can significantly improve not only short-term effect,but also long-term efficacy,and safer.
作者 孙刚
出处 《四川医学》 CAS 2012年第10期1776-1777,共2页 Sichuan Medical Journal
关键词 恶性胶质瘤 放疗 化疗 malignant glioma radiotherapy chemotherapy
  • 相关文献

参考文献7

二级参考文献11

  • 1史建军,邵汛帆,莫志文,张书旭,邓敬锋.24例恶性脑胶质瘤术后三维适形放射治疗分析[J].肿瘤学杂志,2005,11(5):377-378. 被引量:9
  • 2熊晓鹏,孔琳,胡超苏.放射治疗合并替莫唑胺治疗多形性胶质母细胞瘤的研究[J].中国神经肿瘤杂志,2005,3(4):290-295. 被引量:15
  • 3Randes A A,Brmani M,Basso U,et al.Temozolomide as asecondline systemic remmen in recurrent high-grade glioma:aphaseⅡ study[J].Ann Onclo,2001,12(2):255-257. 被引量:1
  • 4Stupp R,Mason W P,van den Bent M J,et al.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J].N Engl J Med,2005,352(10):987-996. 被引量:1
  • 5Stupp R,Hegi M E,Mason W P,et al.Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase Ⅲ study:5-year analysis of the EORTC-NCIC trial[J].Lancet Oncol,2009,10(5):459-466. 被引量:1
  • 6Gorlia T,van den Bent M J,Heqi M E,et al.Nomograms for predicting survival of patients with newly diagnosed glioblastoma:prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3[J].Lancet Oncol,2008,9(1):29-38. 被引量:1
  • 7Aldape K,Burger P C,Perry A.Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma[J].Arch Pathol Lab Med,2007,131(2):242-251. 被引量:1
  • 8Brandes AA, Turazzi S, Basso U, et al. A multidrug combination designed for reversing resistance to BCNU in glioblastoma[J]. Neurology,2002,58(12) :1759. 被引量:1
  • 9陈东福等著,殷蔚伯,谷铣之.肿瘤放射治疗学[M]中国协和医科大学出版社,2002. 被引量:1
  • 10李玉,田启和,吴凤桐,薛洪利,王军.治疗135例脑恶性星形细胞瘤的探讨[J].中华放射肿瘤学杂志,1996,5(1):11-13. 被引量:19

共引文献30

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部